Arch to raise $600M for tenth fund

Arch Venture Partners is raising $600 million for its Arch Venture Fund X LP, according to an SEC filing. The firm declined to provide details, although the filing notes that no capital has been raised yet.

Arch’s life sciences portfolio includes cancer detection company Grail Inc. (Menlo Park, Calif.) and DNA synthesis company Twist Bioscience Corp. (San Francisco, Calif.)...